United States Securities and Exchange Commission · EDGAR Accession 0002051498-25-000002

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-35469
Issuer CIK 2051498
Raising via StartEngine Primary, LLC

AlphaRose Therapeutics Inc

CorporationDEIncorporated 2023AUSTIN, TXalpharose.com
Progress updateAt the close of the offering, the issuer closed on $1,583,596.78 anhd 1,812,846 number of securities.
A

The Offering

as disclosed in this filing
Common Stock
$1.35
$19,999
$4,999,999
September 29, 2025
Expired 258 days ago
$0max $4,999,999

Target is 0% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 201%1 employee
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(625,253)0
Total assets614,4980
Cash & equivalents525,84549,990▲ 952%
Accounts receivable00
Short-term debt81,0980
Long-term debt1,151,0980
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-35469 · all filings under this campaign
Loading campaign history…